Cerus Newsroom

Cantor Fitzgerald Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $4

Futu NewsOct 31 19:31

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Futu NewsOct 31 11:32

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Futu NewsOct 30 21:31

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Futu NewsOct 29 21:31

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Futu NewsOct 28 21:31

Cerus Is Maintained at Buy by Stifel

Dow JonesOct 17 22:53

Cerus Analyst Ratings

BenzingaOct 17 22:44

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Futu NewsOct 17 21:34

Cerus (CERS) Gets a Buy From Craig-Hallum

TipRanksOct 17 20:47

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Futu NewsOct 17 20:31

Stifel Maintains Cerus(CERS.US) With Buy Rating, Cuts Target Price to $3

Futu NewsOct 17 20:31

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Futu NewsOct 17 10:32

Optimistic Future for Cerus: Buy Rating Despite EU Setback, Support From BARDA Boosts US Prospects

TipRanksOct 17 10:27

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Futu NewsAug 2 21:34

Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Cerus (CERS) and Ultragenyx Pharmaceutical (RARE)

TipRanksAug 2 21:05

Stifel Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $6

Futu NewsAug 2 20:31

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Futu NewsAug 2 18:36

Cerus's Strong Q1 Growth and Promising INTERCEPT Technology Drive Buy Rating

TipRanksMay 5 18:50

Canto Fitzgerald: Maintaining the Cerus (CERS.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $3.00 to $4.00.

Zhitong FinanceMay 3 23:20

Cerus Analyst Ratings

BenzingaMay 3 23:20